At the time of writing, Jasper Therapeutics Inc [JSPR] stock is trading at $23.24, up 2.70%. An important factor to consider is whether the stock is rising or falling in short-term value. The JSPR shares have gain 10.77% over the last week, with a monthly amount glided 3.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jasper Therapeutics Inc [NASDAQ: JSPR] stock has seen the most recent analyst activity on September 09, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $70. Previously, BTIG Research started tracking the stock with Buy rating on July 08, 2024, and set its price target to $90. On June 27, 2024, Stifel initiated with a Buy rating and assigned a price target of $86 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $65 on May 06, 2024. Evercore ISI initiated its recommendation with a Outperform and recommended $65 as its price target on April 03, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 28, 2024, and assigned it a price target of $70. In a note dated March 18, 2024, TD Cowen initiated an Outperform rating.
For the past year, the stock price of Jasper Therapeutics Inc fluctuated between $4.00 and $31.01. Currently, Wall Street analysts expect the stock to reach $34.75 within the next 12 months. Jasper Therapeutics Inc [NASDAQ: JSPR] shares were valued at $23.24 at the most recent close of the market. An investor can expect a potential return of 49.53% based on the average JSPR price forecast.
Analyzing the JSPR fundamentals
Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at -33.47%, Pretax Profit Margin comes in at -30.96%, and Net Profit Margin reading is -30.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -0.68 and Total Capital is -0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.65 points at the first support level, and at 22.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 23.84, and for the 2nd resistance point, it is at 24.44.
Ratios To Look Out For
It is important to note that Jasper Therapeutics Inc [NASDAQ:JSPR] has a current ratio of 7.61. On the other hand, the Quick Ratio is 7.61, and the Cash Ratio is 7.42.
Transactions by insiders
Recent insider trading involved Mahal Jeetinder Singh, Chief Operating Officer, that happened on Sep 12 ’24 when 900.0 shares were sold. Executive Officer, Jeetinder Singh Mahal completed a deal on Sep 12 ’24 to buy 900.0 shares. Meanwhile, Chief Operating Officer Mahal Jeetinder Singh sold 900.0 shares on Jun 12 ’24.
